Call Start: 08:30 January 1, 0000 9:06 AM ET
Aspira Women's Health, Inc. (AWH)
Q1 2022 Earnings Conference Call
May 11, 2022, 08:30 ET
Company Participants
Nicole Sandford - President, Chief Executive Officer and Director
Robert Beechey - Chief Financial Officer
Michael Newton - Head, Commercial
Conference Call Participants
Brian Weinstein - William Blair & Company
Ross Osborn - Cantor Fitzgerald & Co.
Operator
Good morning ladies and gentlemen and welcome to Aspira Women's Health Inc. First Quarter 2022 Earnings Conference Call. My name is Tom and I will be your coordinator for the call today. Leading the call today are Nicole Sandford, President and Chief Executive Officer and Bob Beechey, Chief Financial Officer. After prepared remarks we will open the call for Q&A.
Before we begin, I would like to remind everyone that forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995, will be made during this call, including statements relating to Aspira's expected future performance, future business prospects or future events or plans. Although the company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, actual outcomes and results are subject to risks and uncertainties and could differ materially from those anticipated due to the impact of many factors beyond the control of Aspira.
The company assumes no obligation to update or supplement any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Participants are directed to the cautionary note set forth in today's press release as well as the risk factors set forth in Aspira's most recent Form 10-K filed with the SEC for a description of factors that could cause actual results to differ materially from those anticipated in the forward-looking statements.
At this time, I'd like to turn
- Read more current AWHL analysis and news
- View all earnings call transcripts